Therapeutic Effect and Prognosis of Biliary Tract Tumor Transformation.

Biliary tract tumor is a common malignant disease in clinical practice. Its incidence rate and mortality rate are high, which seriously endangers the health of the people. At present, gastrointestinal surgery is mainly used to treat patients at home and abroad. This paper discusses the main risk factors of biliary tract cancer transformation, analyzes its prognostic characteristics and clinical efficacy, and compares them by comprehensive evaluation methods such as observation group control method, blood routine examination and treatment. The results are as follows: the postoperative adverse reactions in the control group are more obvious than those in the experimental group. There were no obvious clinical manifestations or adverse reactions in the experimental group. The therapeutic effect of biliary tumor transformation can effectively help patients improve their quality of life. Through the prognosis recovery of biliary tract tumor transformation treatment, the health level of patients in the experimental group was higher than that in the control group.

1. Introduction

Biliary tract tumor is a common malignant tumor in clinic. Its causes and treatment approaches are diverse, among which the most important are patients' irregular diet, disease severity, and psychological factors. The treatment of biliary tract cancer is mainly carried out through chemotherapy, but serious complications will occur due to patients' low immunity, poor body resistance, and clinical incompatibility to a certain extent. At present, abdominal infiltration and intra-abdominal injection are widely used in China. However, although these operations can reduce the probability of adverse reactions and improve the efficacy and safety, it has no obvious effect on most malignant tumors, so the postchemotherapy treatment scheme of biliary tract cancer came into being and has been recognized and praised by clinicians. However, patients with biliary tract tumors have serious complications in clinical treatment, which is also one of the causes of death. The formation of this series of problems is related to the physiological characteristics of patients with biliary tract cancer. Therefore, we should strengthen the study on the prognosis of gallbladder cancer after operation.

Many scholars have studied the treatment of biliary tract tumors. At present, there are few studies on the treatment of patients after acute intra-abdominal connective tissue surgery in China. In the research reports in China, many cases show that the vast majority of patients with biliary tract cancer have had serious complications, such as diabetes insipidus leading to respiratory disorder. Patients with cirrhosis and renal insufficiency also suffer from various cardiovascular diseases, and even cause cardio-cerebrovascular permeability inflammation etc.; these diseases will have varying degrees of impact on patients. Dandan and others believe that signet ring cell carcinoma of the biliary system is rare in clinic, often starts in the middle-aged and elderly people, and occurs in the gallbladder. The clinical symptoms are mostly the symptoms of the right upper abdomen and jaundice. If it is complicated with cholecystitis and gallstones, it may also be the relevant cause of the disease. Adenocarcinoma with signet ring cell carcinoma is common in the types of lesions, and the degree of malignancy is high. Most patients are in the middle and late stages of cancer at the initial diagnosis, Surgery is the main diagnostic method, but the benefit of radiotherapy and chemotherapy needs to be further studied, so the overall prognosis is poor [1]. Hoshimoto et al. evaluated the relationship between the proliferation ability of squamous cell carcinoma (SCC) components in biliary adenosquamous carcinoma (ASC) and their proportion and tumor progression [2]. Iida and Kusama illustrate the surgical practicability and limitations of endoscopic retrograde cholangiography (ERC) by comparing with drip cholangiography (DIC). The diagnostic significance of DIC before ERC shows that it plays a certain role in screening patients [3]. Mandika et al. found that galectin can promote tumor transformation or regulate cell growth, apoptosis, and immune cells and cause tumor invasion, progression, metastasis, and angiogenesis. These glycan binding proteins have been shown to be involved in the regulation of different tumor suppressor genes and oncogenes and may play a role in human cancer [4]. Colloca and Venturino analyzed the effect of family history of colorectal cancer and tumor along the colorectal on the overall survival of a series of patients with metastatic colorectal cancer with synchronous metastasis [5]. Qi et al. studied the biological behavior characteristics and patient survival rate of gastrointestinal stromal tumor (GIST) with PDGFRA mutation, clarified the efficacy of imatinib treatment, and also studied the relationship between gene mutation and gist biological behavior, patient prognosis, and imatinib treatment effect [6]. Li et al. screened aldolase B (aldob) by QRT PCR array of glycolysis-related genes in 5 pairs of liver metastases and primary colorectal cancer and then further detected aldob protein in 229 patients with stage I-III colorectal cancer by tissue microarray (TMA). They used crispr-cas9 method to establish aldob knockout colon cancer cell lines (LoVo and SW480). The effects of aldob on cell proliferation and metastasis were detected by colony formation assay and crosspore migration and invasion assay in vitro. In TMA, 64.6% of the samples showed strong aldob. In univariate and multivariate regression analysis, high expression of aldob was associated with low overall survival and disease-free survival (P < 0.05). The functional study of CCK-8 in vitro showed that silencing aldob expression significantly inhibited the proliferation, migration, and invasion of colon cancer cells (P < 0.05). Mechanically, silencing of aldob activated epithelial markers and inhibited mesenchymal markers suggesting that aldob inactivation may lead to inhibition of epithelial mesenchymal transformation (EMT). Upregulation of aldob promotes colorectal cancer metastasis by promoting EMT and serves as a potential prognostic factor and therapeutic target for colorectal cancer [7]. Tsai et al. studied the clinical application of plod3 in judging the prognosis of glioma. The biological role of plod3 in GBM cell proliferation, migration, and invasion was studied by wound healing, Transwell experiment, and orthotopic xenotransplantation mouse model. Hypoxia and Western blotting were used to discover the molecular mechanism of plod3 function. Compared with normal brain tissue, the expression of plod3 mRNA and protein was upregulated in glioma tissue. The main diseases of biliary tract cancer are gastrointestinal infection, enteritis, and bladder cancer. The incidence of nephropathy is high and multiple. The incidence rate of liver injury is [8]. Some foreign scholars have analyzed the clinical efficacy and prognosis of middle- and late-stage cases. The results showed that there was no significant difference in the treatment of biliary tract tumors in recent 30 days (P < 0.01), among which renal insufficiency and gastrointestinal tract lesions were the main symptoms. The above research has laid the foundation for this paper.

The clinical manifestations of patients with biliary tract tumors are closely related to the disease, and the main pathological information includes age, signs, and family genetic history, mainly younger. Therefore, this study found that the incidence of gallbladder cancer in patients was high and showed an upward trend. Among them, cardiovascular and cerebrovascular diseases and hepatic artery injury are one of the most important factors leading to the increased risk of disease. This study found that the therapeutic effect of biliary tract tumor transformation can effectively help patients improve their quality of life, which has important research significance for the clinical treatment of biliary tract tumors.

2. Analysis of Therapeutic Effect and Prognosis of Biliary Tract Tumor Transformation

2.1. Hazards of Biliary Tract Tumors

Biliary tract tumors are usually asymptomatic in the early stage and are only accidentally found during physical examination or surgery. If there are symptoms, they are mostly manifested as dull pain in the right upper abdomen, paroxysmal exacerbation, radiation in the right shoulder and waist and back, or dyspepsia, greasiness, belching, abdominal distension, etc.

Malignant tumor of bile duct refers to a rare patient with high heterogeneity from the inner epithelium of bile duct and gallbladder. It can be divided into cholangiocarcinoma and gallbladder cancer. The former can also be divided into intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma according to the anatomical site. The main causes of biliary tract tumors include cystic dilatation of bile duct, biliary calculi, and primary sclerosing cholangitis. Although bile duct malignant tumors are rare in clinic, accounting for about 3% of the malignant tumors of the whole digestive system, their incidence has increased in China and around the world in recent years. The clinical symptoms of the disease are mainly jaundice, gallbladder enlargement, abnormal defecation, liver damage, biliary bleeding and infection, lack of fixed symptoms and signs, and complications such as early lymph node metastasis, vascular invasion, and distant metastasis. The prognosis of biliary tract tumors is very poor. The median survival time of patients with unresectable tumors or metastasis is less than 1 year. The treatment methods of biliary tract tumors include surgical resection, systemic chemotherapy, and targeted radiotherapy. Because most patients are diagnosed in the late stage and lose the opportunity of radical surgery, surgery combined with a variety of adjuvant therapy is the main means of biliary tract tumor treatment, which is aimed at delaying the development of the disease, improving the quality of life, and prolonging the survival time. Especially for patients with positive surgical margin or lymph node involvement, the benefit of adjuvant therapy may be more significant. 5-Fluorouracil and gemcitabine are common chemotherapeutic drugs for biliary tract tumors. 5-Fluorouracil is often used in combination with cisplatin, and the effect is better than that alone. There is evidence that for patients with unresectable cholangiocarcinoma, the combination of 5-fluorouracil and cisplatin can prolong the survival time and improve the quality of life.

2.2. Understanding of Transformation Treatment of Biliary Tract Tumors

Cholangiocarcinoma is a proliferative lymphoma of the gastrointestinal mucosa. It is characterized by ptosis and obvious instability. The patient will relapse 3 days after operation. The clinical manifestations and lesion distribution of patients with biliary tract tumors are different, mainly in their disease types, clinical symptoms, and postoperative dysfunction. In the course of treatment, we should pay attention to observe whether the patient has abnormal behavior or adverse reactions. In the course of treatment, patients with biliary tract tumors are seriously affected by their own diseases, family economy, and other factors. If the patient fails to take effective measures for rescue in time or fails to recover after rescue. Therefore, patients should be transferred and cleared of renal tubular ventilation and other complications. The clinical manifestations of patients with biliary tract cancer are generally stubborn and Qi deficiency, with high incidence rate, difficult treatment, and great influence on the patient's condition. If only conventional methods are used for treatment, patients will have fear of difficulties and fear [9, 10]. Therefore, we should closely observe and actively cooperate with doctors in order to improve the curative effect. In case of severe postoperative pain or other complications, the dose of biliary chemotherapy can be appropriately increased, or the reserved treatment period can be prolonged to reduce the adverse reaction rate. Postoperative patients with biliary tract cancer generally have complications such as fear of tube, balloon, and urinary system. These diseases not only affect the patients themselves but also may lead to the decline of body immunity and even lead to a variety of complications. In clinic, most of them are treated by simple chemotherapy to prevent infection.

2.3. Effect of Biliary Tract Tumor Transformation Therapy on Prognosis

During the treatment of patients, medical staff need to give corresponding rescue measures after the transformation of biliary tract cancer. At the same time, whether to continue the clinical application of the disease is determined according to the efficacy evaluation and future diagnosis results obtained by postoperative chemotherapy. Clinically, patients will experience various degrees of complications during treatment, including gastrointestinal reactions, biliary leakage, and postoperative urinary retention. These may be the causes of infection and recurrence. Before the relief of prognostic symptoms, patients will have varying degrees of pain, mainly manifested in preoperative analgesia, nausea and vomiting during operation, and gastrointestinal dysfunction. During postoperative treatment, the prognosis of patients will have a great impact on the clinical efficacy. The main manifestations are (1) low infiltration rate in the biliary tract. Due to gastrointestinal wall dysfunction, intestinal and gallbladder cell proliferation, and other complications, patients are prone to diabetes insipidus. (2) There was no significant change or abnormal progression of complications during surgical incision, and the signs of preinfection showed a high trend. (3) There is a large difference in the degree of cooperation between the tissues of patients during operation, resulting in an increased risk of recurrence after treatment. (4) Preoperative preparation activities were not fully prepared to prevent adverse reactions [11, 12].

2.4. Detection and Evaluation Indexes of Biliary Tract Tumors

Biliary tract tumor is one of the most common malignant diseases in clinic. Its main cause is that patients have had chronic or nonspecific reactions and a variety of complications due to low immunity and imperfect autoimmune system during treatment. The disease of patients with biliary tract cancer is multiple, which is characterized by long cell cycle, wide distribution, and high degree of damage compared with other types of cancer [13, 14]. In clinic, CT detection technology is usually used to judge whether there is the risk of infection, as well as the analysis of possible complications and death risk after treatment, so as to evaluate the prognosis and clinical efficacy of patients. The diagnosis and treatment of patients with biliary tract cancer is a very complex and arduous task. Its detection technology mainly includes blood biochemical examination, platelet analysis, and tumor cytology observation, among which CT scanner is widely used in clinic. In this paper, precision, recall, and F-score are used as the evaluation indexes of biliary tract tumor detection task. The calculation formula is as follows:

N cdt represents the number of correctly detected tumors, NTD represents the number of detected tumors, and Nttd represents the number of detected tumors. At present, the main clinical method for patients with biliary tract cancer is that the observation group uses a variety of instruments to examine them, including fluorescence and electron microscope. Among them, the most widely used is the use of vascular stenosis detector and pulse wave monitor. Pulse diagnosis and cardiac functional magnetic resonance imaging (LPC) are widely used in clinic [15].

3. Experiment

3.1. Experimental Purpose

Biliary tract disease is a typical chronic complication. Its treatment is simple, its compliance is poor, and its incidence rate is high. Surgical treatment of biliary tract cancer can improve the prognosis and reduce the risk of recurrence. The condition of patients with biliary tract tumors will change with age and living environment. Therefore, how to improve the ability of patients to overcome the disease and prevent recurrent infection is a difficult problem in clinical treatment. The main objectives of this study include the following aspects: (1) to observe and analyze the incidence of biliary tract cancer in various types of patients and the relationship between its causes and complications and (2) to explore whether biliary tumor transformation has an impact on the effective and nonspecific treatment groups of stroke and then to explore how to prevent recurrent infection in different environments.

3.2. Experimental Contents

The experiment was divided into two groups. The first group was treated with routine treatment, and the second group was controlled analysis to observe the transformation progress of biliary tract tumors. There were some differences in clinical efficacy and prognosis between the two groups. In these two groups, the patients underwent physical examination and vital sign examination at admission (as shown in Table 1). In case of any abnormality, communicate with the nurse in time to solve relevant problems. If the patient's condition is serious, inform the doctor to take corresponding measures to reduce symptoms or eliminate hazards. If the ECG test result is positive, you can enter the next treatment process. The clinical symptoms and prognosis of the two groups were observed by routine liver analysis.

Table 1

Basic patient information in both groups.

	Experimental group (n = 25)	Control group (n = 25)
Gender
Man	17	10
Woman	8	15
Age	45 ± 5	42 ± 4
Tumor diameter	3 [2.8]	3 [2.7]
KPS grade	91.34 ± 14.2	90.32 ± 17.2

3.3. Experimental Steps

Patients undergoing resection of biliary tract cancer were divided into groups, the corresponding control treatment scheme was selected according to the patient's age, operation time, and incision type. First, the patients were given routine treatment, including observing the condition, checking whether the urinary catheter and subcutaneous artery were unobstructed. After confirming the need for surgical resection, the patients who had been diagnosed with cholecyst complicated with intraperitoneal incision or resection were directly injected with semidigestive system vulva and gastrointestinal fluid according to the ICU process, combined with whole blood functional exercise clothes for routine treatment, so as to ensure that the patients can get a good recovery effect. Gallbladder cells were dissected 30 minutes before operation, and hemodynamic data and blood coagulation indexes were recorded. Then, through subcutaneous injection and pelvic extraction technology, the obstruction phenomenon and prognosis recovery of patients during operation were analyzed. In the observation group, different concentrations of ammonia threshold were compared with the conventional two groups to observe the angiographic changes and intraoperative bleeding after the transformation of biliary tract cancer.

4. Discussion

4.1. Comparative Analysis of Efficacy and Adverse Reactions of Biliary Tract Tumor Transformation Therapy

Table 2 shows the data of adverse reactions in the transformation treatment of biliary tract tumors in the control group and the experimental group.

Table 2

Test data (N, %).

Group	Experimental group		Control group
	L-II linear measure	II-IV linear measure	LI linear measure	III-IV linear measure
Leucopenia	7 (17.39)	5 (2.17)	17 (28.07)	6 (12.28)
Hemoglobin reduction	15 (30.43)	3 (4.35)	24 (40.35)	5 (7.02)
Thrombocytopenia	8 (19.57)	4 (8.70)	17 (33.33)	4 (15.79)
Gastrointestinal reaction	17 (39.13)	5 (4.35)	27 (45.61)	3 (5.26)
Liver function injury	7 (10.87)	2 (2.17)	15 (21.05)	2 (14.04)
Renal function injury	5 (8.70)	2 (2.17)	5 (12.28)	3 (5.26)

Patients with biliary tract tumors will have some adverse reactions before and after treatment, including the occurrence, development, and metastasis of gastrointestinal diseases. It is mainly reflected in the following two aspects. One is intestinal dysfunction. Digestive system disorder is caused by the lack or influence of water extract and starch and protease inhibitors in the spleen. Second, the abnormal increase of abdominal congestion factor caused by liver and kidney dysfunction and other nutritional fiber-related diseases leads to nausea and vomiting in patients with biliary tract cancer. By analyzing the complications before and after biliary tumor transformation in the two groups during treatment, the results are shown in Figure 1. The postoperative adverse reactions in the control group are more obvious than those in the experimental group. This comparison shows that the patients in the experimental group have no particularly obvious clinical manifestations or adverse reactions.

Figure 1

The comparison of the adverse reaction data in the biliary tumor transformation treatment with the experimental group.

4.2. Comparative Analysis of Pain Relief in the Treatment of Biliary Tract Tumor Transformation

Table 3 shows the comparative data of pain relief between the two groups.

Table 3

Comparison of pain relief rates between the experimental and control groups.

Pain degree	Experimental group	Control group	P
None	7	4	0.04
Temperate	10	7	0.05
Severe	8	14	0.01

As can be seen from Figure 2, among the 50 patients, there were 11 patients without obvious postoperative pain, including 4 in the control group and 7 in the experimental group. After statistical analysis, the pain and analgesia effect was better before and after treatment (P = 0.04). There were 17 patients with mild postoperative pain, including 7 in the control group and 10 in the experimental group. After statistical analysis, there was a statistical difference (P = 0.05). There were 22 patients with strong postoperative pain, including 14 in the control group and 8 in the experimental group. After statistical analysis, there was a statistical difference (P = 0.01).

Figure 2

Performance comparison of postoperative pain relief in the two groups.

4.3. Comparative Analysis of Quality of Life of Patients with Prognosis

As can be seen from Figure 3, after 50 patients received different treatments, their quality of life improved differently. In the control group, there were 5 patients with improved quality of life, 13 patients with stable quality of life, 7 patients with reduced quality of life, and 18 overall effective patients. At the same time, in the experimental group, there were 10 patients with improved quality of life, 10 stable patients, 5 reduced patients, and 20 overall effective patients. This shows that the therapeutic effect of biliary tumor transformation can effectively help patients improve their quality of life.

Figure 3

Comparison of patient quality of life.

4.4. Analysis of Patient Prognosis Health Scale

The Nottingham Health Scale contains 38 items, including six dimensions: emotional response, energy, sleep, pain, social life, and physical activities. It is mainly used to study the quality of life and evaluate the treatment measures of prognostic tumor patients. The highest score of any latitude is 100 points, and the lowest score is 0. Score by the patient's response. The final total score is the sum of dimension item scores. The higher the score, the more problems and the worse the quality of life. As can be seen from Figure 4, the score of the control group is higher than that of the experimental group, which indicates that the prognosis of the experimental group is restored through the transformation treatment of biliary tract tumors, and the health level of the patients in the experimental group is higher than that of the control group.

Figure 4

Prognostic patient health scale scores for comparison.

5. Conclusion

Patients with biliary tract tumors usually have complications after operation. During the operation, the main reason is the decrease of immune function and disease resistance caused by bile duct stenosis. Therefore, we can strengthen nursing intervention to improve patients' disease resistance and prevent recurrence risk. At the same time, we also need to pay close attention to the changes of patients' vital signs and give treatment guidance in time. For patients with gastrointestinal tumors, we should also pay attention to the prognosis, recovery time, and curative effect. Clinically, we can take corresponding measures according to the specific condition to reduce the probability of complications. This paper discusses the main risk factors of biliary tract cancer transformation, analyzes its prognostic characteristics and clinical efficacy, and compares them by comprehensive evaluation methods such as observation group control method, blood routine examination, and treatment.

There are still many imperfections in this paper, and future research will make corresponding supplements. For example, increase the comparison of higher tumor treatment methods to highlight the advantages of this method.